| FH535 |
ENSG00000132204.9 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000145063.10 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000149656.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000152487.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000152487.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000170919.11 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000172965.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000174365.15 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000175611.7 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000177337.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000177738.3 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000177757.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000178803.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000179523.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000179743.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000179935.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000180139.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000181800.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000182057.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000182057.4 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000182310.8 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000182310.8 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000182366.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000182586.3 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000183535.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000184068.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000184068.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000184324.11 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000185203.7 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000186056.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000186594.8 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000188206.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000189229.10 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000189419.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000196559.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000196668.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000196668.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000196810.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000196951.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000196960.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000197332.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000197463.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000197813.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000198468.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000203325.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000203497.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000203497.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000203499.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000203865.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000204187.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000204623.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000204706.10 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000204791.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000204929.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000205037.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000205054.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000205500.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000205885.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000205885.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000205890.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000206142.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000206195.6 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000211683.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000212163.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000213742.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000213793.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000213793.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000214184.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000214407.3 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000214770.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000214770.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000214894.2 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000215241.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000215417.6 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000215692.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000218839.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000219665.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000222035.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000222043.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000223356.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000223393.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000223478.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000223573.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000223653.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000223734.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000223759.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000223768.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000223791.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000223813.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000223834.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000223855.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000223891.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000223901.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000223907.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000224046.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000224049.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000224057.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000224157.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000224173.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000224220.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000224292.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000224342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000224358.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000224394.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000224429.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000224509.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000224574.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000224577.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000224592.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000224609.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000224623.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000224626.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000224699.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000224707.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000224713.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000224717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000224764.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000224883.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000224885.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000224934.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000224972.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000224992.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000224995.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000225037.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000225075.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000225092.2 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000225113.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000225138.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000225138.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000225140.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000225179.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000225205.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000225218.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000225234.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000225279.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000225315.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000225331.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000225335.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000225335.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000225335.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000225377.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000225377.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000225411.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000225489.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000225506.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000225518.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000225518.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000225518.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000225527.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000225572.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000225667.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000225798.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000225822.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000225857.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000225873.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000225914.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000225931.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000225975.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000225981.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000226067.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000226088.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000226113.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000226167.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000226245.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000226281.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000226291.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000226302.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000226310.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000226330.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000226375.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000226381.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000226419.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000226445.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000226465.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000226622.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000226637.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000226649.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000226669.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000226688.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000226746.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000226752.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000226756.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000226853.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000226869.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000226899.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000226957.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000227014.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000227014.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000227036.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000227036.2 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000227060.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000227083.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000227110.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000227248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000227253.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000227258.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000227258.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000227279.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000227285.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000227285.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000227359.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000227374.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000227375.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000227388.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000227486.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000227487.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000227492.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000227540.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000227640.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000227704.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000227740.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000227741.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000227773.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000227844.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000227888.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000227895.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000227896.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000227946.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000227953.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000228010.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000228037.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000228079.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000228108.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000228113.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000228126.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000228242.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000228242.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000228293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000228302.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000228323.2 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000228369.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000228382.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000228393.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000228393.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000228412.2 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000228414.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000228437.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000228444.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000228527.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000228540.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000228548.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000228661.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000228679.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000228701.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000228709.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000228779.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000228801.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000228817.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000228838.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000228857.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000228973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000228989.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000228989.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000229043.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000229044.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000229127.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000229131.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000229162.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000229214.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000229228.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000229368.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000229491.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000229537.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000229618.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000229628.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000229839.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000229950.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000229953.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000229956.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000230021.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000230068.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000230084.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000230212.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000230289.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000230289.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000230316.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000230427.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000230433.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000230433.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000230439.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000230530.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000230530.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000230534.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000230536.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000230561.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000230612.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000230615.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000230615.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000230633.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000230684.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000230736.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000230790.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000230817.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000230836.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000230896.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000230912.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000231023.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000231025.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000231050.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000231064.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000231081.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000231104.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000231128.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000231154.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000231185.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000231201.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000231227.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000231249.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000231329.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000231365.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000231407.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000231439.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000231481.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000231519.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000231551.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000231691.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000231713.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000231724.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000231728.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000231734.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000231754.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000231769.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000231789.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000231840.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000231856.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000231877.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000231881.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000231948.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000231971.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000232063.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000232079.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000232093.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000232098.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000232104.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000232131.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000232233.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000232233.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000232310.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000232311.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000232311.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000232487.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000232533.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000232545.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000232564.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000232564.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000232586.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000232611.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000232623.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000232640.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000232640.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000232645.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000232698.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000232712.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000232725.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000232732.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000232756.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000232827.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000232891.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000232907.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000232907.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000232912.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000233080.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000233137.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000233137.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000233178.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000233184.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000233220.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000233221.2 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000233251.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000233293.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000233368.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000233411.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000233461.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000233527.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000233532.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000233593.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000233695.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000233695.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000233757.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000233818.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000233847.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000233854.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000233862.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000233895.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000233903.2 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000233903.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000233906.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000233937.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000233975.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000234019.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000234050.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000234072.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000234084.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000234206.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000234225.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000234232.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000234263.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000234281.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000234290.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000234327.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000234393.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000234405.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000234423.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000234437.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000234456.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000234478.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000234535.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000234676.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000234771.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000234818.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000234848.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000234917.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000234921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000234936.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000234978.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000235007.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000235079.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000235091.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000235100.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000235100.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000235111.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000235204.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000235209.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000235214.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000235246.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000235271.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000235271.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000235326.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000235387.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000235410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000235437.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000235475.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000235495.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000235499.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000235545.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000235635.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000235635.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000235641.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000235652.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000235706.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000235726.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000235726.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000235795.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000235872.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000235897.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000235899.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000235910.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000235919.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000235939.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000235958.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000235999.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000236017.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000236021.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000236081.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000236098.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000236137.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000236144.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000236194.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000236213.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000236234.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000236266.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000236305.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000236423.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000236472.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000236510.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000236526.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000236537.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000236540.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000236558.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000236663.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000236703.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000236711.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000236719.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000236824.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000236830.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000236850.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000236859.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000236869.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000236869.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000236871.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000236901.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000236935.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000236947.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000236991.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000237021.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000237027.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000237036.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000237036.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000237063.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000237101.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000237149.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000237310.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000237328.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000237331.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000237357.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000237357.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000237385.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000237423.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000237453.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000237476.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000237485.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000237499.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000237502.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000237517.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000237517.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000237594.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000237596.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000237689.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000237756.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000237857.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000237892.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000237899.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000237903.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000237919.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000237938.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000237978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000238018.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000238039.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000238058.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000238062.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000238123.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000238140.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000238164.2 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000238198.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000238279.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000238287.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000239213.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000239335.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000239407.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000239445.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000239445.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000239569.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000239911.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000239920.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000240005.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000240063.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000240137.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000240211.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000240401.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000240497.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000240571.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000240591.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000240618.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000240996.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000241211.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000241280.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000241449.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000241520.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000241570.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000241570.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000241679.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000241770.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000241770.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000241818.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000241954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000242086.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000242207.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000242282.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000242516.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000242540.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000242759.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000242791.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000242791.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000242808.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000243176.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000243224.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000243224.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000243368.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000243491.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000243701.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000243902.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000244137.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000244184.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000244265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000244300.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000244332.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000244380.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000244380.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000244513.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000244513.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000244625.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000244945.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000244998.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000245146.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000245248.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000245275.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000245330.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000245468.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000245498.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000245532.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000245571.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000245598.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000245857.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000246089.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000246130.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000246174.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000246225.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000246225.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000246375.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000246662.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000246731.2 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000246763.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000246790.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000246790.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000246851.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000247092.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000247516.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000247595.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000247624.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000247765.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000247774.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000247934.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000247982.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000248092.3 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000248112.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000248202.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000248243.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000248243.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000248275.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000248300.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000248309.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000248318.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000248367.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000248473.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000248559.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000248664.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000248693.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000248693.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000248724.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000248774.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000248918.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000248925.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000248980.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000249028.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000249054.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000249159.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000249258.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000249328.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000249348.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000249364.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000249379.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000249426.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000249430.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000249509.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000249550.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000249572.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000249593.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000249673.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000249685.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000249685.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000249700.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000249700.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000249740.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000249846.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000250033.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000250132.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000250159.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000250286.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000250286.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000250295.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000250320.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000250326.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000250360.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000250421.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000250519.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000250608.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000250765.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000250802.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000250938.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000250950.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000250971.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000250988.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000250990.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000251023.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000251054.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000251131.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000251138.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000251141.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000251148.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000251165.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000251168.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000251169.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000251187.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000251370.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000251405.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000251497.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000251555.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000251562.3 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000251573.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000251603.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000253121.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000253167.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000253190.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000253298.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000253301.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000253357.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000253358.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000253372.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000253372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000253405.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000253420.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000253479.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000253641.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000253669.3 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000253698.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000253720.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000253737.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000253829.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000253837.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000253837.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000253893.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000253930.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000253955.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000253961.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000254057.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000254099.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000254258.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000254340.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000254353.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000254363.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000254427.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000254428.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000254461.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000254461.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000254485.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000254495.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000254510.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000254556.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000254615.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000254631.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000254662.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000254670.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000254671.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000254671.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000254718.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000254777.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000254860.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000254878.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000254910.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000254934.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000254936.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000254973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000254990.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000255052.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000255094.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000255094.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000255100.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000255153.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000255165.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000255176.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000255197.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000255197.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000255299.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000255306.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000255306.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000255308.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000255334.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000255355.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000255414.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000255421.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000255449.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000255455.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000255456.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000255458.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000255487.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000255521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000255571.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000255669.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000255670.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000255750.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000255929.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000255933.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000255980.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000255989.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000256011.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000256226.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000256250.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000256312.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000256417.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000256442.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000256442.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000256542.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000256943.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000256967.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000256967.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000257056.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000257083.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000257084.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000257126.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000257135.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000257139.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000257270.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000257279.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000257337.2 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000257346.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000257496.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000257497.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000257543.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000257556.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000257568.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000257595.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000257613.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000257702.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000257815.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000257815.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000258001.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000258017.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000258044.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000258044.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000258096.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000258102.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000258136.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000258137.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000258188.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000258303.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000258437.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000258442.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000258454.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000258458.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000258458.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000258525.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000258545.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000258556.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000258561.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000258675.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000258704.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000258733.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000258733.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000258735.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000258760.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000258760.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000258821.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000258845.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000258851.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000258902.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000258914.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000258920.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000258935.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000258938.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000258940.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000258940.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000258949.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000258999.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000259093.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000259153.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000259163.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000259178.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000259182.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000259206.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000259209.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000259212.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000259212.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000259230.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000259240.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000259248.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000259310.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000259319.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000259322.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000259345.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000259345.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000259349.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000259353.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000259362.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000259364.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000259365.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000259365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000259380.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000259396.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000259417.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000259417.2 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000259424.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000259437.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000259453.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000259456.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000259469.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000259475.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000259481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000259499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000259523.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000259598.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000259598.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000259623.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000259656.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000259663.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000259673.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000259700.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000259715.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000259736.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000259767.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000259767.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000259768.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000259792.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000259792.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000259797.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000259797.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000259802.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000259826.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000259901.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000259933.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000259935.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000259935.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000259943.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000259943.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000259954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000259972.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000259986.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000260005.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000260017.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000260037.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000260038.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000260060.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000260065.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000260086.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000260088.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000260118.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000260123.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000260136.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000260177.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000260193.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000260193.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000260194.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000260196.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000260209.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000260233.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000260256.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000260261.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000260273.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000260276.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000260278.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000260281.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000260285.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000260289.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000260331.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000260336.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000260360.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000260400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000260420.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000260423.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000260441.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000260466.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000260466.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000260470.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000260507.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000260515.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000260517.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000260526.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000260526.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000260534.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000260558.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000260565.2 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000260588.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000260593.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000260593.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000260630.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000260635.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000260637.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000260643.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000260646.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000260661.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000260664.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000260671.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000260672.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000260693.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000260743.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000260743.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000260757.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000260774.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000260778.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000260792.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000260803.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000260810.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000260814.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000260831.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000260831.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000260877.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000260884.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000260896.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000260920.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000260924.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000260936.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000260942.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000260948.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000260976.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000260986.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000261002.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000261005.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000261008.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000261008.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000261019.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000261024.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000261030.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000261043.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000261064.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000261094.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000261118.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000261135.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000261141.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000261170.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000261173.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000261183.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000261185.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000261187.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000261187.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000261188.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000261204.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000261207.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000261218.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000261220.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000261235.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000261251.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000261252.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000261286.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000261294.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000261360.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000261372.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000261396.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000261423.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000261433.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000261447.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000261455.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000261462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000261471.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000261512.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000261523.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000261542.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000261596.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000261610.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000261644.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000261646.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000261669.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000261670.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000261692.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000261731.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000261757.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000261766.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000261775.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000261801.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000261838.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000261879.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000261879.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000261925.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000262001.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000262089.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000262136.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000262155.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000262172.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000262188.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000262202.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000262265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000262434.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000262468.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000262482.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000262668.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000262693.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000262810.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000262837.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000262881.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000262903.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000262966.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000263015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000263069.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000263098.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000263164.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000263164.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000263272.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000263338.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000263350.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000263412.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000263477.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000263499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000263551.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000263674.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000263680.2 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000263717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000263766.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000263843.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000263847.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000263884.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000263916.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000263924.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000263924.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000263982.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000264000.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000264012.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000264112.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000264188.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000264207.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000264270.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000264304.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000264339.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000264365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000264448.2 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000264456.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000264469.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000264575.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000264608.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000264635.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000264812.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000264914.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000264920.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000265055.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000265091.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000265130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000265142.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000265142.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000265316.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000265458.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000265490.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000265519.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000265656.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000265845.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000265845.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000266049.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000266053.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000266289.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000266401.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000266402.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000266466.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000266473.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000266473.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000266498.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000266601.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000266783.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000266805.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000266911.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000266912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000266916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000266926.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000266941.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000266969.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000266978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000267011.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000267016.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000267042.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000267044.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000267044.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000267093.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000267100.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000267104.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000267118.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000267131.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000267147.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000267152.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000267192.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000267194.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000267219.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000267219.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000267249.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000267255.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000267263.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000267272.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000267289.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000267296.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000267298.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000267304.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000267321.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000267345.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000267366.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000267381.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000267390.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000267390.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000267419.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000267429.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000267446.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000267457.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000267461.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000267475.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000267481.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000267501.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000267504.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000267546.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000267546.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000267565.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000267568.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000267582.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000267582.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000267582.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000267606.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000267666.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000267677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000267705.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000267715.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000267750.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000267758.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000267759.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000267787.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000267834.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000267834.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000267871.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000267874.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000267898.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000267927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000267940.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000268027.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000268047.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000268049.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000268049.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000268066.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000268095.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000268119.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000268199.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000268201.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000268230.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000268257.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000268266.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000268289.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000268392.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000268401.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000268471.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000268499.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000268543.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000268568.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000268583.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000268601.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000268649.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000268655.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000268670.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000268836.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000268873.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000268912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000268931.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000268945.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000268970.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000269044.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000269054.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000269086.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000269091.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000269102.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000269161.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000269161.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000269191.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000269235.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000269290.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000269293.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000269293.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000269386.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000269397.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000269425.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000269463.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000269473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000269481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000269534.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000269534.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000269609.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000269646.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000269646.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000269653.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000269656.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000269806.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000269825.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000269834.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000269834.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000269836.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000269895.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000269898.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000269902.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000269903.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000269925.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000269942.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000269946.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000269947.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000269976.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000269978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000269990.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000270001.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000270006.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000270006.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000270012.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000270017.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000270019.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000270035.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000270061.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000270067.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000270072.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000270083.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000270091.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000270095.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000270095.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000270117.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000270127.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000270130.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000270133.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000270157.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000270165.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000270171.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000270178.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000270190.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000270237.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000270361.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000270419.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000270462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000270604.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000270605.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000270605.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000270605.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000270607.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000270659.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000270681.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000270742.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000270755.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000270761.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000271009.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000271020.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000271020.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000271032.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000271109.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000271151.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000271185.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000271199.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000271200.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000271218.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000271228.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000271259.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000271265.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000271335.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000271384.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000271398.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000271401.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000271427.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000271643.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000271643.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000271643.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000271716.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000271751.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000271761.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000271778.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000271782.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000271782.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000271782.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000271803.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000271833.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000271840.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000271848.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000271856.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000271857.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000271888.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000271889.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000271938.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000271948.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000271981.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000271991.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000271992.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000271998.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000272010.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000272030.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000272033.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000272043.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000272043.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000272048.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000272068.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000272077.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000272088.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000272097.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000272142.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000272143.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000272180.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000272183.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000272205.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000272205.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000272250.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000272275.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000272288.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000272335.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000272354.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000272365.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000272374.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000272379.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000272384.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000272384.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000272416.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000272416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000272430.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000272444.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000272444.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000272446.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000272449.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000272452.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000272462.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000272463.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000272516.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000272520.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000272520.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000272524.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000272525.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000272574.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000272576.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000272644.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000272669.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000272677.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000272696.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000272699.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000272699.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000272716.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000272717.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000272717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000272717.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000272732.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000272755.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000272760.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000272760.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000272763.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000272764.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000272769.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000272788.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000272788.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000272795.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000272800.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000272812.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000272824.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000272828.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000272829.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000272834.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000272853.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000272859.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000272870.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000272871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000272885.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000272892.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000272895.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000272913.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000272914.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000272933.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| FH535 |
ENSG00000272949.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000272949.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000272966.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000272977.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000273001.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000273008.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000273026.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000273108.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000273148.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000273162.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000273181.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000273183.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000273257.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| FH535 |
ENSG00000273290.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000273295.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000273297.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| FH535 |
ENSG00000273302.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| FH535 |
ENSG00000273305.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000273319.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000273321.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000273344.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000273355.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000273366.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000273399.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| FH535 |
ENSG00000273402.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000273428.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| FH535 |
ENSG00000273428.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| FH535 |
ENSG00000273448.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000273456.1 |
Predicted lncRNA |
Esophageal cancer |
|
| FH535 |
ENSG00000273486.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| FH535 |
ENSG00000273486.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| FH535 |
ENSG00000273493.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
